Athelas develops technology to monitor chronically ill patients in their homes.
Athelas's investors include General Catalyst, Sequoia Capital, Tribe Capital, Y Combinator, Greenoaks.
Athelas is headquartered in Mountain View, United States.
Athelas develops technology to monitor chronically ill patients in their homes.
Athelas is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Athelas — Funding & Investors." VCBacked, January 31, 2022, https://www.vcbacked.co/company/athelas. Accessed July 31, 2026.
VCBacked. (2022). Athelas — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/athelas
{{cite web |title=Athelas — Funding & Investors |url=https://www.vcbacked.co/company/athelas |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated